0002-8900 : Taltz 20 mg/.25ml Subcutaneous Injection, Solution


NDC: 0002-8900
Labeler: Eli Lilly and Company
Product Type: Human Prescription Drug
Drug Name:  Taltz
Dosage Form: Subcutaneous Injection, Solution
Application #: BLA125521
Rev. Date: 


NDC Package Codes:

  • 0002-8900-11: 1 SYRINGE IN 1 CARTON (0002‑8900‑11) / 1 ML IN 1 SYRINGE (0002‑8900‑01)

Active Ingredients:

  • Ixekizumab

Dosage Strength:

  • 20 mg/.25mL

Pharmaceutical Classes:

  • Interleukin-17A Antagonist [EPC]
  • Interleukin-17A Antagonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0002-1445 Taltz 80 mg/ml Subcutaneous Injection, Solution by Eli Lilly and Company
  • 0002-7724 Taltz 80 mg/ml Subcutaneous Injection, Solution by Eli Lilly and Company
  • 0002-8905 Taltz 40 mg/.5ml Subcutaneous Injection, Solution by Eli Lilly and Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0002-8900 QR Code

< Prev: 0002-8870Next: 0002-8905 >

Related Discussions:

What to use topically with Taltz
I've been on Taltz for a year now,and I am very pleased with the drug, as it has gotten me about 98%clear. In the la...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.